Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|January 16, 2020
Chemical analysis of snus products from the United States and northern EuropeTameka S Lawler, Stephen B Stanfill, Hang T Tran, et al.Journal of Medicinal Chemistry|January 13, 2015
Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spreadYi Shen, Craig A Zificsak, Jill E Shea, et al.Bioorganic & Medicinal Chemistry Letters|December 3, 2010
Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitorsLinda R Weinberg, Mark S Albom, Thelma S Angeles, et al.Bioorganic & Medicinal Chemistry Letters|November 2, 2011
2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formationLinda R Weinberg, Mark S Albom, Thelma S Angeles, et al.Analytical Chemistry|September 21, 2017
Development of a Cigarette Tobacco Filler Standard Reference MaterialLane C Sander, Jeanita S Pritchett, Yasmine C Daniels, et al.Tobacco Regulatory Science|January 19, 2016
Characterization of SPECTRUM Variable Nicotine Research CigarettesPatricia Richter, Pappas R Steven, Roberto Bravo, et al.Journal of Medicinal Chemistry|May 9, 2012
Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinaseDiane E Gingrich, Joseph G Lisko, Matthew A Curry, et al.Journal of Medicinal Chemistry|August 24, 2011
2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activityGregory R Ott, Gregory J Wells, Tho V Thieu, et al.Journal of Medicinal Chemistry|August 17, 2016
Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)Gregory R Ott, Mangeng Cheng, Keith S Learn, et al.Pageof 2